Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNLOGIC, INC. Director's Dealing 2015

Oct 6, 2015

35028_dirs_2015-10-06_03ecf28f-8bff-4509-85c1-c821288da06c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mirna Therapeutics, Inc. (MIRN)
CIK: 0001527599
Period of Report: 2015-10-05

Reporting Person: Sofinnova Venture Partners VIII, L.P. (10% Owner)
Reporting Person: Sofinnova Management VIII, L.L.C. (10% Owner)
Reporting Person: HEALY JAMES (10% Owner)
Reporting Person: AKKARAJU SRINIVAS (10% Owner)
Reporting Person: Mehra Anand (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-05 Common Stock C 1244269 Acquired 1244269 Direct
2015-10-05 Common Stock C 583559 Acquired 1827828 Direct
2015-10-06 Common Stock J 289841 Acquired 2117669 Direct
2015-10-06 Common Stock P 857142 $7 Acquired 2974811 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-05 Series C Preferred Stock $ C 1244269 Disposed Common Stock (1244269) Direct
2015-10-05 Series D Preferred Stock $ C 583559 Disposed Common Stock (583559) Direct

Footnotes

F1: Each share of Series C and Series D Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering.

F2: The shares are held by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII") is the general partner of SVP VIII. The individual Managers, or the Managing Members, of SM VIII are Michael Powell, James Healy, Srinivas Akkaraju and Anand Mehra. The Managers share voting and dispositive power with regard to the shares held directly by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares owned by SVP VIII except to the extent of any pecuniary interest therein.

F3: The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series C and Series D Preferred Stock of the Company.

F4: The expiration date is not relevant to the conversion of the securities.

F5: Due to a clerical error, the Reporting Persons' Form 3 which previously reported the holding of these shares understated his total by one (1) share.